Upper Tract Tumors
Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma.
April 16, 2024
Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ.
April 16, 2024
Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel.
April 12, 2024
Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy.
April 10, 2024
Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.
March 22, 2024
Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor.
March 20, 2024
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.
March 20, 2024
A Nomogram for Predicting Renal Insufficiency in UTUC After Radical Nephroureterectomy - Expert Commentary
March 12, 2024
Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma.
March 7, 2024